Editorial Expression of Concern: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
- PMID: 33203442
- PMCID: PMC8133354
- DOI: 10.1186/s12941-020-00394-8
Editorial Expression of Concern: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Expression of concern for
-
Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.Ann Clin Microbiol Antimicrob. 2016 Apr 26;15:27. doi: 10.1186/s12941-016-0143-3. Ann Clin Microbiol Antimicrob. 2016. PMID: 27112143 Free PMC article.
References
-
- Wong D, Wong T, Romney M, Leung V. Comparison of outcomes in patients with methicillin-susceptible Staphylococcusaureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study. BMC Infect Dis. 2016;16:224. doi: 10.1186/s12879-016-1564-5. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
